TCA
SNTI icon

Taconic Capital Advisors’s Senti Biosciences Holdings SNTI Stock Holding History

Taconic Capital Advisors’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$4.94M – 731
2022
Q1 		$4.94M Hold
50,000
– – 0.13% 174
2021
Q4 		$4.93M Buy
+50,000
New +$4.98M 0.14% 153

Other funds holding SNTI

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
FMN
Financial Management Network Mission Viejo, California $697M AUM 21.37% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return

Taconic Capital Advisors's SNTI Position: Q2 2022 in Review

Taconic Capital Advisors sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 50,000 shares — an estimated $4.94M sold.

Taconic Capital Advisors first reported a position in SNTI in Q4 2021 and held it in 2 quarters. The position peaked at $4.94M in Q1 2022. 22 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

  • Taconic Capital Advisors reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
  • Taconic Capital Advisors sold 50,000 Senti Biosciences Holdings shares in Q2 2022, an estimated $4.94M.
  • Taconic Capital Advisors first reported a position in Senti Biosciences Holdings in Q4 2021 and held it in 2 quarters.
  • Taconic Capital Advisors's Senti Biosciences Holdings position peaked at $4.94M in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on Taconic Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.